Evidence map›Paper›PMID 42535648›Full record

ArticleNucleic acids research2026

In vitro properties of large serine integrase hybrids derived from ϕC31 and TG1 integrases.

Makeba Lawson-Williams, Alexandria Holland, Adebayo J Bello, Phoebe A Rice, Femi J Olorunniji

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Makeba Lawson-WilliamsSchool of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, United Kingdom.
Alexandria HollandSchool of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, United Kingdom.
Adebayo J BelloSchool of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, United Kingdom.
Phoebe A RiceDepartment of Biochemistry & Molecular Biology, The University of Chicago, Chicago IL 60637, United States.ORCID 0000-0002-3467-341X
Femi J OlorunnijiSchool of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, United Kingdom.ORCID 0000-0001-9389-2981

Funding

National Science Foundation NSF/BIO 2223480National Science Foundation UKRI/BBSRC BB/X012085/1UK Research and InnovationWellcome TrustWellcome Trust 316534/Z/24/Z
6 · The paper itself

Abstract

Phage-derived serine integrases are site-specific recombinases from the large serine recombinase (LSR) family that catalyse precise DNA rearrangements. Their high specificity and unidirectional activity make them attractive tools for genome engineering and synthetic biology. However, their strict sequence requirements limit application to predefined target sites. Here, we report in vitro activities of hybrid integrases derived from ϕC31 and TG1 integrases that efficiently recombine hybrid attP × attB substrates while preserving interaction with the cognate recombination directionality factor (RDF) via the TG1-derived coiled-coil domain. These hybrid recombinases retain site discrimination and catalyse attL × attR recombination exclusively in the presence of the appropriate RDF, indicating preserved directionality control. Analysis of the activities of hybrid integrases across a panel of hybrid substrates highlight the importance of DNA-binding domains-att site recognition motifs in governing specificity. This study presents a modular framework for engineering programmable serine integrases with tailored specificity. Combined with structural prediction tools and expanded LSR discovery and characterization, this strategy holds promise for rational design of recombinases targeting custom genomic sites.

Indexed as

BacteriophagesIntegrasesAttachment Sites, MicrobiologicalDNADNA NucleotidyltransferasesModels, MolecularRecombination, GeneticSerineSiphoviridaeSubstrate SpecificityDNADNA NucleotidyltransferasesIntegrasesSerineSite-specific recombinase

Identifiers

PMID42535648
PMCPMC13425240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.